{"disease":{"id":"hemophagocytic-syndrome","name":"hemophagocytic syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT06339177","title":"Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05882175","title":"Prospective Validation of the OHI Index","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT05936086","title":"A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"shifeng Lou","has_results":false},{"nct_id":"NCT06614998","title":"Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"The Affiliated Hospital of Xuzhou Medical University","has_results":false},{"nct_id":"NCT04500886","title":"Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06244862","title":"JAK Inhibitor in Acquired Hemophagocytic synDrome in the Intensive Care Unit","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04999878","title":"A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Zhengzhou University","has_results":false},{"nct_id":"NCT07424222","title":"Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":16,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT05532826","title":"Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT","phase":"NA","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT02400463","title":"A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Michigan Rogel Cancer Center","has_results":true},{"nct_id":"NCT03513328","title":"Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT05236764","title":"Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3,"lead_sponsor_name":"Baylor College of Medicine","has_results":true}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}